Proteomic analysis of subiculum region during AD pathogenesis

Name: Proteomic analysis of subiculum region during AD pathogenesis
Creator: Dalian Institute of Chemical Physics, Chinese Academy of Sciences
Published: 2024-10-18T16:26:28+08:00

integrated proteome resources2026-02-07 收录

阿尔茨海默病蛋白质组学

神经退行性疾病生物标志物

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0009991000 数据链接链接失效反馈

官方服务：

资源简介：

Proteomic analysis of subiculum region during AD pathogenesis

提供机构：

Dalian Institute of Chemical Physics, Chinese Academy of Sciences

创建时间：

2024-10-18

Additional file 4: of Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimerâ s disease

阿尔茨海默病蛋白质组学

基因本体富集分析

Table S4. Gene ontology (GO) term enrichment for differentially expressed proteins in AD. The enriched GO terms with associated P values (Benjamini-Hochberg FDR corrected) for biological processes, ce

Figshare2023-06-01 更新100

Baseline Characteristics of Participants.

神经退行性疾病生物标志物

痴呆风险

BackgroundDementia is a leading cause of cognitive decline, with Alzheimer’s disease (AD) and vascular dementia (VaD) being the most common subtypes. The intraindividual difference between the estimat

Figshare2026-03-06 更新10

Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort

神经退行性疾病生物标志物

基因表达药物靶点预测

Patients with amyotrophic lateral sclerosis (ALS), a rare fatal neurodegenerative disease, face a lengthy diagnostic process, and, although most survive only 2 to 4 years from diagnosis, lack informat

NIAID Data Ecosystem00

Table_2_Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review.XLSX

阿尔茨海默病遗传通路

神经退行性疾病生物标志物

Alzheimer's disease (AD) is a complex neurodegenerative disease, affecting a significant part of the population. The majority of AD cases occur in the elderly with a typical age of onset of the diseas

NIAID Data Ecosystem70

Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

神经退行性疾病生物标志物

质谱蛋白质组学分析

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, p

Figshare2016-01-18 更新10

Proteomic analysis of subiculum region during AD pathogenesis

资源简介：

相关数据集